Cited 0 times in
Optimal sequencing of the first- and second-line target therapies in metastatic renal cell carcinoma: based on nationally representative data analysis from the Korean National Health Insurance System
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.